Popular Press

Ophthalmologie Nachrichten recently featured an article from the ELZA Institute, highlighting advancements in corneal cross-linking (CXL). This new approach allows the procedure to be conducted at the slit lamp, significantly reducing costs and extending access to advanced eye care in underserved regions. The innovative method is especially effective for treating keratoconus and infectious keratitis. By optimizing UV exposure times, ELZA’s researchers have made CXL more efficient and accessible, democratizing high-quality ophthalmic treatments globally.
Nikki Hafezi, a partner of MESCA Foundation, is leading healthcare transformation in Uzbekistan. MESCA, founded in 2021 by Bakhtiyor Fazylov, focuses on medical education, training, and research. It aims to enhance ophthalmological care, particularly addressing keratoconus, a significant cause of preventable blindness in children. MESCA’s initiatives include training local healthcare professionals and collaborating with institutions like the Andijan State Medical Institute to improve medical practice and education.
When considering eyelid surgery, choosing an oculoplastic surgeon ensures specialized care for both cosmetic and functional outcomes. With extensive training in ophthalmology and plastic surgery, oculoplastic surgeons offer unparalleled expertise in the periorbital region. Discover why an oculoplastic surgeon should be your top choice for safe, precise, and aesthetically pleasing results.
Discover the latest advancements in keratoconus treatment with the ELZA Institute’s innovative techniques: transPRK, PACE, and All Femto-CAIRS, as featured in The Ophthalmologist.
The “Schweizerischen Ärztezeitung” (the Swiss Medical Journal) recently reported on ELZA’s consultant glaucoma surgeon, Prof. Dr. med. Kaweh Mansouri’s appointment as the Executive Vice President of the World Glaucoma Association (WGA) in an article titled “He fights against glaucoma”. This appointment marks the first time a Swiss and European specialist has been elected to this position within the WGA.
In a recent feature, Ocular Surgery News (OSN) provided an in-depth overview of the latest advancements in epi-on crosslinking, as presented by Prof. Farhad Hafezi of the ELZA Institute at the Winter ESCRS meeting in Frankfurt, Germany.
The newspapers Tages-Anzeiger, Der Bund, and Basler Zeitung published a story on laser eye surgery complications, and featured ELZA’s Medical Director, Prof. Farhad Hafezi as the expert contributor to the article.
Let’s delve into the insightful presentations given by two of ELZA’s finest surgeons during ELZA at Swiss Ophthalmological Society (SSO)’s Swiss Eye Week 2024, highlighting the contributions of ELZA’s Medical Director, Prof. Farhad Hafezi and consultant glaucoma surgeon, Prof. Kaweh Mansouri on Wednesday, January 17th, 2024. The conference was held to educate Switzerland’s up and coming ophthalmology residents, and is a highly anticipated meeting each year. This year, the meeting was held at that Belvédère Strandhotel, Spiez.
The Ophthalmologist’s “CXL: What’s New in 2023?” article explores advancements in corneal collagen crosslinking for treating keratoconus. ELZA’s Farhad Hafezi discusses how CXL has advanced to the current state of the art, and highlights new breakthroughs like sub400 and PACE.
.
.